Print Friendly, PDF & Email

NCT/Study#

NCT04720664 /

OASIS

OASIS: Phase II Trial Of Oral SM-88 In Patients With Metastatic Hormone Receptor-Positive HER2-Negative (HR+/HER2-) Breast Cancer.

DISEASE GROUP:

Breast Cancer Clinical Trials

current phase:

Phase II

STUDY STATUS:

Active

Location:

Hackensack, NJ

For More information:

Call 201-518-3587